BioDelivery Sciences International, Inc. (BDSI) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate BioDelivery Sciences International, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
3.78
Strong
WeakModerateStrong
P/B Ratio
1.70
Strong
WeakModerateStrong
Earnings Yield
26.50%
Strong
WeakModerateStrong
Profitability Health
2021Return on Equity
45.18%
Strong
WeakModerateStrong
Operating Margin
22.27%
Strong
WeakModerateStrong
Net Profit Margin
50.90%
Strong
WeakModerateStrong
Growth Indicators
2021Revenue Growth
6.54%
Moderate
WeakModerateStrong
Net Income Growth
230.05%
Strong
WeakModerateStrong
EPS Growth
215.38%
Strong
WeakModerateStrong
Efficiency & Liquidity
2021Current Ratio
2.45
Strong
WeakModerateStrong
Quick Ratio
2.17
Strong
WeakModerateStrong
Asset Turnover
0.51x
Moderate
WeakModerateStrong
Inventory Turnover
0.99x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
12.69%
Strong
WeakModerateStrong
EV / Free Cash Flow
6.52x
Strong
WeakModerateStrong
Net Debt / EBITDA
-1.25x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.798
Weak
WeakModerateStrong
Return on Invested Capital
15.04%
Moderate
WeakModerateStrong
Cash Conversion Cycle
368.08 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BDSI.
View Financial Statements